Metformin decreased myocardial fibrosis and apoptosis in hyperhomocysteinemia -induced cardiac hypertrophy

Joseph, 2003, Hyperhomocysteinemia leads to pathological ventricular hypertrophy in normotensive rats, Am J Physiol Heart Circ Physiol, 285, 679, 10.1152/ajpheart.00145.2003 Guldener, 2000, Hyperhomocysteinemia, vascular pathology, and endothelial dysfunction, Semin Thromb Hemost, 26, 281, 10.1055/s-2000-8472 Krishna, 2013, The potential role of homocysteine mediated DNA methylation and associated epigenetic changes in abdominal aortic aneurysm formation, Atherosclerosis, 228, 295, 10.1016/j.atherosclerosis.2013.02.019 Azad, 2018, Hyperhomocy steinemia and cardiovascular disease in animal model, Amino Acids, 50, 3, 10.1007/s00726-017-2503-5 Diwan, 2007, Decompensation of cardiac hypertrophy: cellular mechanisms and novel therapeutic targets, Physiology (Bethesda), 22, 56 Heineke, 2003, Downregulation of Cytoskeletal Muscle LIM Protein by Nitric Oxide, Circulation, 107, 1424, 10.1161/01.CIR.0000055319.94801.FC Lips, 2003, Molecular determinants of myocardial hypertrophy and failure: alternative pathways for beneficial and maladaptive hypertrophy, Eur Heart J, 24, 883, 10.1016/S0195-668X(02)00829-1 Pryor, 2015, Repurposing metformin: an old drug with new tricks in its binding pockets, Biochem J, 471, 307, 10.1042/BJ20150497 Messaoudi, 2013, Metformin therapy in diabetes: the role of cardioprotection, Curr Atheroscler Rep, 15, 314, 10.1007/s11883-013-0314-z Feng, 2010, Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway, Cardiovasc Res, 87, 504, 10.1093/cvr/cvq066 Legtenberg, 2002, Metformin improves cardiac functional recovery after ischemia in rats, Horm Metab Res, 34, 182, 10.1055/s-2002-26705 Foody, 2003, Metformin and thiazolidinedione use in Medicare patients with heart failure, JAMA, 290, 81, 10.1001/jama.290.1.81 Ables, 2015, Dietary methionine restriction in mice elicits an adaptive cardiovascular response to hyperhomocysteinemia, Sci Rep, 5, 8886, 10.1038/srep08886 Dick, 2019, Self-renewing resident cardiac macrophages limit adverse remodeling following myocardial infarction, Nat Immunol, 20, 29, 10.1038/s41590-018-0272-2 Saxena, 2014, CXCR3-independent actions of the CXC chemokine CXCL10 in the infarcted myocardium and in isolated cardiac fibroblasts are mediated through proteoglycans, Cardiovasc Res, 103, 217, 10.1093/cvr/cvu138 Hirota, 1999, Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress, Cell, 97, 189, 10.1016/S0092-8674(00)80729-1 Jensen, 2014, Novel metabolic biomarkers of cardiovascular disease, Nat Rev Endocrinol, 10, 659, 10.1038/nrendo.2014.155 Wheeler, 2003, Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) study, Kidney Int Suppl, S201, 10.1046/j.1523-1755.63.s84.45.x Mitsnefes, 2008, Cardiovascular complications of pediatric chronic kidney disease, Pediatr Nephrol, 23, 27, 10.1007/s00467-006-0359-0 Zoccali, 2002, A. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients, Kidney Int, 61, 609, 10.1046/j.1523-1755.2002.00242-1.x Nasir, 2007, Elevated homocysteine is associated with reduced regional left ventricular function, Circulation, 115, 180, 10.1161/CIRCULATIONAHA.106.633750 Vasan, 2003, Plasma homocysteine and risk for congestive heart failure in adults without prior myocardial infarction, JAMA, 10, 1251, 10.1001/jama.289.10.1251 Clarke, 2010, Effects of lowering homocysteine levels with B vitamins on cardiovascular disease, cancer, and cause-specific mortality: meta-analysis of 8 randomized trials involving 37 485 individuals, Arch Intern Med, 18, 1622 Liu, 2010, A novel rat model of heart failure induced by high methionine diet showing evidence of association between hyperhomocysteinemia and activation of NF-kappaB, Am J Transl Res, 8, 117 Ewis SA, Abdel-Rahman MS. Effect of metformin on glutathione and magnesium in normal and streptozotocin-induced diabetic rats. J Appl Toxicol.1995 15(5):387-390. Techiryan, 2018, Effect of intracoronary metformin on myocardial infarct size in swine, Circ Res, 123, 986, 10.1161/CIRCRESAHA.118.313341 Efentakis, 2019, Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin, Blood, 133, 710, 10.1182/blood-2018-06-858415 Sanchez-Rangel, 2017, Metformin: clinical use in type 2 diabetes, Diabetologia, 60, 1586, 10.1007/s00125-017-4336-x Sun, 2017, Metformin improves cardiac function in mice with heart failure after myocardial infarction by regulating mitochondrial energy metabolism, Biochem Biophys Res Commun, 486, 329, 10.1016/j.bbrc.2017.03.036 Marniemi, 2004, Elevated plasma homocysteine level is an independent predictor of coronary heart disease events in patients with type 2 diabetes mellitus, Ann Intern Med, 140, 94, 10.7326/0003-4819-140-2-200401200-00009 Buysschaert, 2000, Hyperhomocysteinemia in type 2 diabetes: relationship to macroangiopathy, nephropathy, and insulin resistance, Diabetes Care, 12, 1816, 10.2337/diacare.23.12.1816 Sasaki, 2009, Metformin prevents progression of heart failure in dogs: role of AMP-activated protein kinase, Circulation, 119, 2568, 10.1161/CIRCULATIONAHA.108.798561